Efficient synthesis of bicyclic oxazolino- and thiazolino[3,2-c]pyrimidine- 5,7-diones and its application to the synthesis of GnRH antagonists

Bioorganic and Medicinal Chemistry Letters

Volumn 15, Issue 5, 2005, Pages 1407-1411

  Pontillo, Joseph ^a   Chen, Chen ^a  

^a NEUROCRINE BIOSCIENCES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZENE DERIVATIVE; CARBONYL DERIVATIVE; CHLOROCARBONYL ISOCYANATE; GONADORELIN ANTAGONIST; ISOCYANIC ACID DERIVATIVE; OXAZOLINE DERIVATIVE; PYRIMIDINE DERIVATIVE; SULFUR DERIVATIVE; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG SYNTHESIS; STRUCTURE ACTIVITY RELATION;

EID: 13944252005     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2005.01.009     Document Type: Article

References (26)

1. A.V. Schally, A. Arimura, A.J. Kastin, H. Matsuo, Y. Baba, T.W. Redding, R.M.G. Nair, L. Debeljuk, and W.F. White Science 173 1971 1036
2. B. Kutscher, M. Bernd, T. Beckers, E.E. Polymeropoulos, and J. Engel Angew. Chem., Int. Ed. 36 1997 2149 and references cited therein
3. J. Cui, R.G. Smith, G.R. Mount, J.L. Lo, J. Yu, T.F. Walsh, S.B. Singh, R.J. DeVita, M.T. Goulet, J.M. Schaeffer, and K. Cheng Mol. Endocrinol. 14 2000 671
4. W. Zhou, V. Rodic, S. Kitanovic, C.A. Flanagan, L. Chi, H. Weinstein, S. Maayani, R.P. Millar, and S.C. Sealfon J. Biol. Chem. 270 1995 18853
5. E. Kardamakis, and V. Tzingounis J. Marsoukas T. Mavromoustakos Biomedical Health Research: Bioactive Peptides in Drug Discovery and Design: Medical Aspects Vol. 22 1999 IOS Amsterdam 275 285
6. S. Sasaki, N. Cho, Y. Nara, M. Harada, S. Endo, N. Suzuki, S. Furuya, and M. Fujino J. Med. Chem. 46 2003 113
7. R.J. Devita, T.F. Walsh, J.R. Young, J. Jiang, F. Ujjainwalla, R.B. Toupence, M. Parikh, S.X. Huang, J.A. Fair, M.T. Goulet, M.J. Wyvratt, J.L. Lo, N. Ren, J.B. Yudkovitz, Y.T. Yang, K. Cheng, J. Cui, G. Mount, S.P. Rohrer, J.M. Schaeffer, L. Rhodes, J.E. Drisko, E. McGowen, D.E. MacIntyre, S. Vincent, J.R. Carlin, J. Cameron, and R.G. Smith J. Med. Chem. 44 2001 917 and references cited therein
8. J.R. Young, S.X. Huang, T.F. Walsh, M.J. Wyvratt, Y.T. Yang, J.B. Yudkovitz, J. Cui, G.R. Mount, R.N. Ren, T.J. Wu, X. Shen, K.A. Lyons, A.H. Mao, J.R. Carlin, B.V. Karanam, S.H. Vincent, K. Cheng, and M.T. Goulet Bioorg. Med. Chem. Lett. 12 2002 827 and references cited therein
9. D.R. Luthin, Y. Hong, E. Tompkins, K.L. Anderes, G. Paderes, E.A. Kraynov, M.A. Castro, K.D. Nared-Hood, R. Castillo, M. Gregory, H. Vazir, J.M. May, and M.B. Anderson Bioorg. Med. Chem. Lett. 12 2002 827
10. F.C. Tucci, Y.-F. Zhu, Z. Guo, T.D. Gross, P.J. Conners, R.S. Struthers, G.J. Reinhart, X. Wang, J. Saunders, and C. Chen Bioorg. Med. Chem. Lett. 12 2002 3491 and references cited therein
11. Y.-F. Zhu, Z. Guo, T.D. Gross, Y. Gao, P.J. Conners, R.S. Struthers, Q. Xie, and F.C. Tucci J. Med. Chem. 46 2003 1769 and references cited therein
12. Z. Guo, Y.-F. Zhu, T.D. Gross, F.C. Tucci, Y. Gao, M. Moorjani, P.J. Connors Jr., M.W. Rowbottom, Y. Chen, R.S. Struthers, Q. Xie, J. Saunders, G. Reinhart, T.K. Chen, A.L. Killam-Bonneville, and C. Chen J. Med. Chem. 47 2004 1259
13. G.J. Reinhart, Q. Xie, X.-J. Liu, Y. Zhu, J. Fan, C. Chen, and R.S. Struthers J. Biol. Chem. 33 2004 34115
14. Neurocrine, unpublished result
15. For examples, see: B.A. Otter, E.A. Falco, and J.J. Fox J. Org. Chem. 33 1968 3593
16. K. Tanai, and O. Maruyama J. Carbohydr. Nucleos. Nucleot. 3 1976 25
17. T. Maruyama, S. Sato, and M. Honjo Chem. Pharm. Bull. 30 1982 2688
18. H. Urata, H. Miyagoshi, H. Kakuya, H. Tokumoto, T. Kawahata, T. Otake, and M. Akagi Chem. Pharm. Bull. 46 1998 458
19. Bayer Patent (Germany) DE 2126148; Chem. Abstr. 1972, 78, 11360
20. The oxazolines 4a, 4c-d and thiazoline 5a were purchased from Sigma-Aldrich. The oxazoline 4b was purchased from Lancaster Synthesis
21. The oxazoline 4e was synthesized according to known literature procedures, see: C.M. Shafer, and T.F. Molinski J. Org. Chem. 61 1996 2044
22. The thiazolines 5b-f were synthesized according to known literature procedures, see: R.A. Aitken, D.P. Armstrong, R.H.B. Galt, and S.T.E. Mesher J. Chem. Soc., Perkin Trans. 1 1997 2139
23. 13C NMR, LCMS, and elemental analysis or HRMS
24. 3: 230.0691, found 230.0686
25. K. Kamata, and I. Agata J. Org. Chem. 63 1998 3113
26. All final compounds were evaluated for their ability to inhibit des-Gly10[125I-Tyr5, DLeu6, NMeLeu7, Pro9-NEt]-GnRH radioligand binding to the cloned hGnRH receptor stably expressed in HEK293 cells, using a 96-well filtration assay format; see: M.H. Perrin, Y. Haas, J.E. Rivier, and W.W. Vale Mol Pharmacol. 23 1983 44 Data are the average of two or more independent experiments